Deccan Healthcare, an Indian developer of nutraceutical products which boost immunity and address chronic ailments, has received a Rs15crore (approximately $3.2m) equity financing from India’s Venture Capital firm Nexus Venture Partners.
Commenting on the deal, Mr Minto Gupta, Founder & CEO of Deccan Healthcare, said: “The funding will help us enhance our R&D efforts and our expansion plans. Deccan is launching a variety of nutraceuticals addressing specific life-style problems and will also explore export opportunities”.
Company’s key products include a flaxseed-based vegetarian Omega-3 which they sell under the OxyFlax and Nulife-ISB brand. It isanti-carcinogenic and anti-inflammatory and useful for cardiac care, bone health, diabetes prevention.
Sandeep Singhal of Nexus Venture Partners will join the Deccan Healthcare board.
The company is based out of Hyderabad, India.
FinSMEs
28/10/2009